Covered recipient · General Payments record
JEFFREY REYES
Physician Assistants & Advanced Practice Nursing Providers Physician Assistant
General Payments · PY2021–2024
$3,516.35
- Reported across 42 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,063.94 | 8 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Averitas Pharma Inc. | $154.05 | 1 |
| Abbott Laboratories | $152.96 | 1 |
| ABBVIE INC. | $150.00 | 1 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | $125.00 | 1 |
| Kiniksa Pharmaceuticals International, plc | $125.00 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $124.88 | 1 |
| Otsuka America Pharmaceutical, Inc. | $122.51 | 1 |
| Acerta Pharma LLC | $109.54 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (8)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $152.96 | 12/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125282793 | CMS |
| ABBVIE INC. | $150.00 | 09/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108077572 | CMS |
| AstraZeneca Pharmaceuticals LP | $109.54 | 12/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104654709 | CMS |
| Averitas Pharma Inc. | $154.05 | 09/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133467995 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $124.88 | 12/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118162534 | CMS |
| Kiniksa Pharmaceuticals International, plc | $125.00 | 12/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154866768 | CMS |
| Otsuka America Pharmaceutical, Inc. | $122.51 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119170594 | CMS |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | $125.00 | 03/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118843465 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.